These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10360795)

  • 1. Effect of gemcitabine on the tolerance of the lung to single-dose irradiation in C3H mice.
    Grégoire V; Cvilic S; Beauduin M; De Coster B; Gueulette J; Octave-Prignot M; Scalliet P
    Radiat Res; 1999 Jun; 151(6):747-9. PubMed ID: 10360795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiosensitization of mouse sarcoma cells by fludarabine (F-ara-A) or gemcitabine (dFdC), two nucleoside analogues, is not mediated by an increased induction or a repair inhibition of DNA double-strand breaks as measured by pulsed-field gel electrophoresis.
    Grégoire V; Beauduin M; Bruniaux M; De Coster B; Octave Prignot M; Scalliet P
    Int J Radiat Biol; 1998 May; 73(5):511-20. PubMed ID: 9652808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetics of mouse jejunum radiosensitization by 2',2'-difluorodeoxycytidine (gemcitabine) and its relationship with pharmacodynamics of DNA synthesis inhibition and cell cycle redistribution in crypt cells.
    Grégoire V; Beauduin M; Rosier JF; De Coster B; Bruniaux M; Octave-Prignot M; Scalliet P
    Br J Cancer; 1997; 76(10):1315-21. PubMed ID: 9374377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The intensification of the radiotherapeutic effect on HeLa cells by gemcitabine].
    Mose S; Karapetian M; Jüling-Pohlit L; Taborski B; Ramm U; Damrau M; Rahn A; Böttcher HD
    Strahlenther Onkol; 1999 Feb; 175(2):78-83. PubMed ID: 10065143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiation enhancement by gemcitabine-mediated cell cycle modulations.
    Mose S; Class R; Weber HW; Rahn A; Brady LW; Böttcher HD
    Am J Clin Oncol; 2003 Feb; 26(1):60-9. PubMed ID: 12576927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiation enhancement of gemcitabine in two human squamous cell carcinoma cell lines.
    Mose S; Karapetian M; Jüling-Pohlit L; Taborski B; Damrau M; Ramm U; Rahn A; Böttcher HD
    Anticancer Res; 2000; 20(1A):401-5. PubMed ID: 10769687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclopentenyl cytosine increases gemcitabine radiosensitisation in human pancreatic cancer cells.
    van Bree C; Rodermond H; Leen R; Medema J; van Kuilenburg A
    Br J Cancer; 2008 Apr; 98(7):1226-33. PubMed ID: 18349845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The radioenhancement of two human head and neck squamous cell carcinomas by 2'-2' difluorodeoxycytidine (gemcitabine; dFdC) is mediated by an increase in radiation-induced residual chromosome aberrations but not residual DNA DSBs.
    Rosier JF; Michaux L; Ameye G; Cedervall B; Libouton JM; Octave-Prignot M; Verellen-Dumoulin C; Scalliet P; Grégoire V
    Mutat Res; 2003 Jun; 527(1-2):15-26. PubMed ID: 12787910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of 2'-2' difluorodeoxycytidine (dFdC, gemcitabine) on radiation-induced cell lethality in two human head and neck squamous carcinoma cell lines differing in intrinsic radiosensitivity.
    Rosier JF; Beauduin M; Bruniaux M; de Bast M; de Coster B; Octave-Prignot M; Scalliet P; Grégoire V
    Int J Radiat Biol; 1999 Feb; 75(2):245-51. PubMed ID: 10072186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of 2',2'-difluorodeoxycytidine on the viability and radiosensitivity of EMT6 cells in vitro.
    Rockwell S; Grindey GB
    Oncol Res; 1992; 4(4-5):151-5. PubMed ID: 1504375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective targeting of homologous DNA recombination repair by gemcitabine.
    Wachters FM; van Putten JW; Maring JG; Zdzienicka MZ; Groen HJ; Kampinga HH
    Int J Radiat Oncol Biol Phys; 2003 Oct; 57(2):553-62. PubMed ID: 12957269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gemcitabine as a radiosensitizer in undifferentiated tumors.
    Kal HB; El Sharouni SY; Barten-van Rijbroek AD
    Anticancer Res; 2006; 26(1A):139-45. PubMed ID: 16475690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mechanistic study of radiosensitization by gemcitabine on human squamous carcinoma cell line of the cervix].
    Miao JW; Kong WM; Zhang WH; Niu JW; Deng XH
    Zhonghua Fu Chan Ke Za Zhi; 2004 May; 39(5):342-5. PubMed ID: 15196420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significant increase in residual DNA damage as a possible mechanism of radiosensitization by gemcitabine.
    Weiss C; Grabenbauer GG; Sauer R; Distel L
    Strahlenther Onkol; 2003 Feb; 179(2):93-8. PubMed ID: 12590319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interaction of gemcitabine and cytarabine on murine leukemias L1210 or P388 and on human normal and leukemic cell growth in vitro.
    Lech-Maranda E; Korycka A; Robak T
    Haematologica; 2000 Jun; 85(6):588-94. PubMed ID: 10870114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiosensitization produced in vivo by once- vs. twice-weekly 2'2'-difluoro-2'-deoxycytidine (gemcitabine).
    Fields MT; Eisbruch A; Normolle D; Orfali A; Davis MA; Pu AT; Lawrence TS
    Int J Radiat Oncol Biol Phys; 2000 Jun; 47(3):785-91. PubMed ID: 10837965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gemcitabine, cisplatin, and hyperfractionated accelerated radiotherapy for locally advanced non-small cell lung cancer.
    Zwitter M; Kovac V; Smrdel U; Strojan P
    J Thorac Oncol; 2006 Sep; 1(7):662-6. PubMed ID: 17409933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of tumor radioresponse in vivo by gemcitabine.
    Milas L; Fujii T; Hunter N; Elshaikh M; Mason K; Plunkett W; Ang KK; Hittelman W
    Cancer Res; 1999 Jan; 59(1):107-14. PubMed ID: 9892194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genotoxicity kinetics in murine normoblasts as an approach for the in vivo action of difluorodeoxycytidine.
    Morales-Ramírez P; Vallarino-Kelly T; Cruz-Vallejo V
    Cancer Chemother Pharmacol; 2017 May; 79(5):843-853. PubMed ID: 28324147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of gemcitabine on cis-platinum-DNA adduct formation and repair in a panel of gemcitabine and cisplatin-sensitive or -resistant human ovarian cancer cell lines.
    Peters GJ; Van Moorsel CJ; Lakerveld B; Smid K; Noordhuis P; Comijn EC; Weaver D; Willey JC; Voorn D; Van der Vijgh WJ; Pinedo HM
    Int J Oncol; 2006 Jan; 28(1):237-44. PubMed ID: 16328001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.